| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
|
Clin Pharmacol Ther
|
2009
|
2.19
|
|
2
|
Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative.
|
J Chromatogr B Biomed Sci Appl
|
2000
|
1.13
|
|
3
|
Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects.
|
Eur J Clin Pharmacol
|
1993
|
1.04
|
|
4
|
Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron.
|
Pharmacogenomics J
|
2010
|
1.01
|
|
5
|
Persistence of haloperidol in human brain tissue.
|
Am J Psychiatry
|
1999
|
0.98
|
|
6
|
Simultaneous determination of 5-aminosalicylic acid and 5-acetylaminosalicylic acid by high-performance liquid chromatography.
|
J Chromatogr
|
1987
|
0.91
|
|
7
|
A simple BASIC program for the calculation of nonparametric confidence intervals in bioequivalence testing.
|
Comput Methods Programs Biomed
|
1987
|
0.86
|
|
8
|
Population pharmacokinetics of piritramide in surgical patients.
|
Anesthesiology
|
1999
|
0.86
|
|
9
|
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.
|
Clin Pharmacol Ther
|
2007
|
0.84
|
|
10
|
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.
|
Clin Pharmacol Ther
|
2008
|
0.84
|
|
11
|
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
|
Int J Clin Pharmacol Ther
|
1994
|
0.83
|
|
12
|
Postprandial changes in supine and erect heart rate, systemic blood pressure and plasma noradrenaline and renin activity in normal subjects.
|
Eur J Clin Pharmacol
|
1987
|
0.83
|
|
13
|
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects.
|
Clin Pharmacol Ther
|
2007
|
0.83
|
|
14
|
Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.
|
Br J Clin Pharmacol
|
1991
|
0.82
|
|
15
|
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1996
|
0.82
|
|
16
|
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs.
|
Clin Pharmacol Ther
|
2007
|
0.82
|
|
17
|
Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteers.
|
Clin Pharmacol Ther
|
2009
|
0.82
|
|
18
|
Influence of urine pH and urinary flow on the renal excretion of memantine.
|
Br J Clin Pharmacol
|
1998
|
0.81
|
|
19
|
SK&F 86466, a novel alpha-adrenolytic drug: effects on heart rate, blood pressure, and neuroendocrine function in supine resting position and in response to postural and cold stimulation in normal humans.
|
J Cardiovasc Pharmacol
|
1989
|
0.81
|
|
20
|
High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
|
J Chromatogr
|
1985
|
0.81
|
|
21
|
Population pharmacokinetics of sevoflurane in conjunction with the AnaConDa: toward target-controlled infusion of volatiles into the breathing system.
|
Acta Anaesthesiol Scand
|
2008
|
0.81
|
|
22
|
Time course and nature of postprandial haemodynamic changes in normal man.
|
Clin Physiol
|
1989
|
0.80
|
|
23
|
Transdermal delivery of mepindolol and propranolol in normal man. 2nd communication: pharmacokinetic and neuro-endocrine aspects.
|
Arzneimittelforschung
|
1989
|
0.78
|
|
24
|
A cell-kinetic model of CD34+ cell mobilization and harvest: development of a predictive algorithm for CD34+ cell yield in PBPC collections.
|
Transfusion
|
2000
|
0.78
|
|
25
|
Effects of the novel D2-dopaminergic agonist ropinirol on supine resting and stimulated circulatory and neuroendocrine variables in healthy volunteers.
|
Arzneimittelforschung
|
1990
|
0.78
|
|
26
|
Pharmacokinetics of mirtazapine: enantioselective effects of the CYP2D6 ultra rapid metabolizer genotype and correlation with adverse effects.
|
Clin Pharmacol Ther
|
2007
|
0.78
|
|
27
|
Genetic variation at the CYP2C locus and its association with torsemide biotransformation.
|
Pharmacogenomics J
|
2006
|
0.78
|
|
28
|
Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age.
|
Eur J Clin Pharmacol
|
1996
|
0.78
|
|
29
|
Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approach.
|
Eur J Clin Pharmacol
|
2002
|
0.78
|
|
30
|
Cardiovascular effects of eating, atenolol and their interaction: beta1-adrenergic modulation does not play a predominant role in the genesis of postprandial effects.
|
Br J Clin Pharmacol
|
1993
|
0.77
|
|
31
|
Region specific distribution of levomepromazine in the human brain.
|
J Neural Transm (Vienna)
|
2005
|
0.77
|
|
32
|
Effects of low-dose atenolol on postural and postprandial changes in heart rate, blood pressure, venous plasma catecholamines, and plasma renin activity.
|
Eur J Clin Pharmacol
|
1989
|
0.76
|
|
33
|
Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA).
|
Br J Clin Pharmacol
|
1992
|
0.76
|
|
34
|
Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?
|
Eur J Clin Pharmacol
|
1997
|
0.75
|
|
35
|
Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.
|
Int Clin Psychopharmacol
|
2000
|
0.75
|
|
36
|
Sensitive high-performance liquid chromatographic determination of pseudoephedrine in plasma and urine.
|
J Chromatogr
|
1988
|
0.75
|
|
37
|
Stability of 5-aminosalicylic acid and 5-acetylaminosalicylic acid in plasma.
|
J Chromatogr
|
1988
|
0.75
|
|
38
|
Pressor tests in clinical pharmacology: response morphology heterogeneity.
|
Methods Find Exp Clin Pharmacol
|
1990
|
0.75
|
|
39
|
Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
|
J Pharm Biomed Anal
|
1989
|
0.75
|
|
40
|
Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man.
|
Arzneimittelforschung
|
1989
|
0.75
|
|
41
|
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
|
Int J Clin Pharmacol Ther
|
1996
|
0.75
|
|
42
|
Sensitive high-performance liquid chromatographic determination of pirenzepine in plasma.
|
J Chromatogr
|
1986
|
0.75
|
|
43
|
Temelastine, a novel histamine H1-receptor antagonist, does not induce oxidative hepatic enzyme activity in man.
|
Eur J Drug Metab Pharmacokinet
|
1987
|
0.75
|